Konst, R. E.
Damman, P.
Pellegrini, D.
van Royen, N.
Maas, A. H. E. M.
Elias-Smale, S. E.
Article History
Accepted: 16 December 2020
First Online: 7 January 2021
Conflict of interest
: P. Damman has received consultancy fees from Philips and Abbott, and research grants from Philips, Abbott and AstraZeneca. R.E. Konst received consultancy fees from Novartis. N. van Royen and S.E. Elias-Smale have received a research grant from Philips and Abbott to perform ongoing trials involving coronary function tests. D. Pellegrini and A.H.E.M. Maas declare that they have no competing interests.